Linezolid in liver failure: exploring the value of the maximal liver function capacity (LiMAx) test in a pharmacokinetic pilot study
- 1 October 2017
- journal article
- research article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 50 (4) , 557-563
Abstract
No abstract availableKeywords
Funding Information
- Charité University Hospital
This publication has 35 references indexed in Scilit:
- Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutionsThe Lancet Infectious Diseases, 2014
- Clinical implications of antibiotic pharmacokinetic principles in the critically illIntensive Care Medicine, 2013
- Software for Dosage Individualization of Voriconazole for Immunocompromised PatientsAntimicrobial Agents and Chemotherapy, 2013
- The effect of critical illness on drug distribution.Current Pharmaceutical Biotechnology, 2011
- Drug metabolism alterations in nonalcoholic fatty liver diseaseDrug Metabolism Reviews, 2011
- Early diagnosis of primary nonfunction and indication for reoperation after liver transplantationLiver Transplantation, 2010
- Pharmacokinetic issues for antibiotics in the critically ill patientCritical Care Medicine, 2009
- Pharmacokinetics and dosage adjustment in patients with hepatic dysfunctionEuropean Journal of Clinical Pharmacology, 2008
- Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of TigecyclineJournal of Chemotherapy, 2005
- Novel antibacterial agents for the treatment of serious Gram-positive infectionsExpert Opinion on Investigational Drugs, 2003